Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. PDS Biotechnology Corporation’s current trading price is -42.64% away from its 52-week high, while its distance from the 52-week low is 170.93%. The stock’s price range over this period has fluctuated between $2.89 and $13.65. The company, operating within the financial sector, had a trading volume of approximately 2.12 million for the day, which was noticeably higher than the average daily share volume of 0.35 million over the last 3 months.
The stock of PDS Biotechnology Corporation (PDSB) is currently priced at $7.83. In the last session, the stock climbed significantly, topping out at $7.22 after opening at $7.22. The day’s lowest price was $6.64 before the stock closed at $6.72.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Sponsored
PDS Biotechnology Corporation experienced a rather steady stock market performance. The highest value in the past year was recorded at $13.65 on 12/30/22 and the lowest value was $2.89 on 10/03/22.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
PDS Biotechnology Corporation (PDSB) has experienced a quarterly rise of 1.29% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 206.84M and boasts a workforce of 26 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 7.53, with a change in price of -2.80. Similarly, PDS Biotechnology Corporation recorded 437,901 in trading volume during the last 100 days, posting a change of -26.36%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for PDSB stands at 0.57. Similarly, the long-term debt-to-equity ratio is also 0.57.
PDSB Stock Stochastic Average
Today, PDS Biotechnology Corporation’s raw stochastic average for the past 50 days stands at 86.82%, indicating a rise from the raw stochastic average of the last 20 days, which was 84.16%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 60.29% and 65.07% respectively.
PDSB Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The metric has seen a significant loss of -40.68% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -7.01%. Over the past 30 days, the price of PDSB has fallen by 28.78%. And in the last five days, it has surged by 5.67%.
